Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Extra Space Storage, Inc. (EXR) vs Novavax Inc (NVAX) Price & Performance

Extra Space Storage, Inc.Trade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Extra Space Storage, Inc. vs Novavax Inc — how do they compare? Extra Space Storage, Inc. trades at $148.89 (market cap $30.56B), while Novavax Inc trades at $8.22 (market cap $1.39B). The key difference: Extra Space Storage, Inc. is far larger — about 22× Novavax Inc's market cap, and Extra Space Storage, Inc. pays a 4.48% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

EXRNVAX
Market Cap
$30.56B$1.39B
Sector
Real EstateHealth
52-Week High
$152.75$11.19
52-Week Low
$126.67$6.22
Enterprise Value
$44.36B$890.94M
Dividend Yield
4.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Extra Space Storage, Inc.

Extra Space Storage (EXR) trades at $145.50, showing modest daily gains of 0.12%. The stock exhibits neutral technical signals with support around $145 and resistance near $146. Fundamentally, the company maintains strong profitability with a 70.63% gross margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights steady expansion and a new $550 million debt issuance at favorable rates, while analyst coverage shows a mixed consensus leaning toward Hold positions.

The outlook for EXR balances steady operational performance against valuation concerns. Investment opportunities include resilient self-storage demand, consistent dividend payments ($1.62 quarterly), and strategic acquisitions. Key risks involve elevated debt levels, new market supply pressures, and expense growth outpacing revenue. With a consensus price target of $155.88 suggesting 7% upside, the stock presents moderate growth potential tempered by sector headwinds.

Novavax Inc

Novavax (NVAX) trades at $8.21, down 2.49% amid bearish technical signals and negative cash flow trends. The company shows mixed fundamentals with strong revenue growth to $1.12B in 2025 and three consecutive earnings beats, but faces profitability challenges with negative net income margin and ROE. Recent news highlights shareholder dissent and underperformance versus broader market trends, while analyst consensus remains bullish with a $14 price target representing 70% upside potential.

The outlook balances significant upside potential against substantial execution risks. Positive catalysts include consistent earnings beats and strong analyst support, but concerns persist around cash burn, negative equity, and competitive vaccine market pressures. Investors face volatility from operational challenges despite attractive valuation multiples.

Returns comparison

Trailing returns across standard periods

About Extra Space Storage, Inc.

Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.

Read more on EXR

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX